Domov › Rakovina endometria › Virginia › Arlington
Klinické štúdie Rakovina endometria v meste Arlington, VA
39 štúdií pre Rakovina endometria hľadá účastníkov v zariadeniach v meste Arlington a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Prebieha náborFáza 2
- Inova Fairfax Hospital, Falls Church · 4 míľ odtiaľ
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Prebieha náborFáza 1
- Site 04, Fairfax · 11 míľ odtiaľ
Study of AVZO-021 in Patients With Advanced Solid Tumors
Prebieha náborFáza 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 míľ odtiaľ
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Prebieha náborFáza 1/2
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Prebieha náborFáza 3
- Inova Schar Cancer Institute ( Site 6003), Fairfax · 11 míľ odtiaľ
- Virginia Cancer Specialists (VCS) ( Site 8008), Fairfax · 11 míľ odtiaľ
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Prebieha náborFáza 1/2
- NEXT Oncology, Fairfax · 11 míľ odtiaľ
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
Prebieha náborFáza 1
- NEXT Oncology, Fairfax · 11 míľ odtiaľ
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Prebieha náborFáza 3
- Research Site, Fairfax · 11 míľ odtiaľ
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Prebieha náborFáza 1
- Inova Schar Cancer Institute, Falls Church · 4 míľ odtiaľ
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Prebieha náborFáza 1/2
- Research Site, Fairfax · 11 míľ odtiaľ
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Prebieha náborFáza 1
- Normunity Investigational Site, Fairfax · 11 míľ odtiaľ
A Study of PHST001 in Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Oncology - Virginia, Fairfax · 11 míľ odtiaľ
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Prebieha náborFáza 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Prebieha náborFáza 3
- Research Site, Falls Church · 4 míľ odtiaľ
- Research Site, Fairfax · 11 míľ odtiaľ
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Prebieha náborFáza 2
- 522, Fairfax · 11 míľ odtiaľ
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 míľ odtiaľ
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Prebieha náborFáza 1/2
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- NEXT, Fairfax · 11 míľ odtiaľ
A Study of LY4175408 in Participants With Advanced Cancer
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Prebieha náborFáza 1
- NEXT Texas LLC - Virginia, Fairfax · 11 míľ odtiaľ
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Prebieha náborFáza 1
- Dren Investigational Site, Fairfax · 11 míľ odtiaľ
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Prebieha náborFáza 2
- Virginia Cancer Specialists, P.C., Fairfax · 11 míľ odtiaľ
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Štúdie Rakovina endometria v iných mestách
- Houston, TX68 štúdií
- New York City, NY52 štúdií
- Boston, MA50 štúdií
- Nashville, TN38 štúdií
- Los Angeles, CA34 štúdií
- St. Louis, MO29 štúdií
- Philadelphia, PA28 štúdií
- San Antonio, TX27 štúdií
- Chicago, IL25 štúdií
- Columbus, OH25 štúdií
- Queens, NY25 štúdií
- Oklahoma City, OK25 štúdií
Iné štúdie v Arlington
- Nemalobunkový karcinóm pľúc104 štúdií
- Metastatická rakovina53 štúdií
- Kolorektálny karcinóm52 štúdií
- Rakovina (všetky typy)48 štúdií
- Rakovina prsníka46 štúdií
- Rakovina vaječníkov46 štúdií
- Rakovina pľúc41 štúdií
- Rakovina pankreasu33 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku26 štúdií
- Malobuněčný rakovina plic23 štúdií
- Trojnásobne negatívny karcinóm prsníka20 štúdií
- Rakovina žalúdka20 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.